Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents
Clinical trial NCT02387294 · COMPLETED
Trial details
- NCT number
- NCT02387294
- Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.